Tuesday, 23 May 2017

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2017 Industry Size, Research, Trends, Review & Analysis to 2022


This report studies Non-steroidal Anti-inflammatory Drugs（NSAID） in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Bayer
Novacap
Abbott
Pfizer
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
Glaxo Smith Kline
Reddy Pharmaceuticals
Johnson & Johnson

                
By types, the market can be split into
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others

By Application, the market can be split into
Back Pain Treatment
Osteoarthritis Treatment
Other

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

                                                                                                                         
Table of Contents     
    
Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Professional Survey Report 2017
1 Industry Overview of Non-steroidal Anti-inflammatory Drugs（NSAID） 1.1 Definition and Specifications of Non-steroidal Anti-inflammatory Drugs（NSAID）
1.1.1 Definition of Non-steroidal Anti-inflammatory Drugs（NSAID）
1.1.2 Specifications of Non-steroidal Anti-inflammatory Drugs（NSAID）
1.2 Classification of Non-steroidal Anti-inflammatory Drugs（NSAID）
1.2.1 Aspirin
1.2.2 Ibuprofen
1.2.3 Naproxen
1.2.4 Nabumetone
1.2.5 Others
1.3 Applications of Non-steroidal Anti-inflammatory Drugs（NSAID）
1.3.1 Back Pain Treatment
1.3.2 Osteoarthritis Treatment
1.3.3 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

….

4 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Overall Market Overview 4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Non-steroidal Anti-inflammatory Drugs（NSAID） Capacity and Growth Rate Analysis
4.2.2 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales and Growth Rate Analysis
4.3.2 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Price
4.4.2 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Price Analysis (Company Segment)

…..

8 Major Manufacturers Analysis of Non-steroidal Anti-inflammatory Drugs（NSAID）
8.1 Bayer 8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Bayer 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Bayer 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Business Region Distribution Analysis
8.2 Novacap 8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Novacap 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Novacap 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Business Region Distribution Analysis
8.3 Abbott 8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Abbott 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Abbott 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Business Region Distribution Analysis
8.4 Pfizer 8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Pfizer 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Pfizer 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Business Region Distribution Analysis
8.5 Geri-Care Pharmaceuticals 8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Geri-Care Pharmaceuticals 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Geri-Care Pharmaceuticals 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Business Region Distribution Analysis
8.6 Perrigo Company 8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Perrigo Company 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Perrigo Company 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Business Region Distribution Analysis
8.7 Kopran 8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Kopran 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Kopran 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Business Region Distribution Analysis
8.8 Merck Sharp & Dohme 8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Merck Sharp & Dohme 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Merck Sharp & Dohme 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Business Region Distribution Analysis
8.9 Sun Pharmaceutical Industries 8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Sun Pharmaceutical Industries 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Sun Pharmaceutical Industries 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Business Region Distribution Analysis
8.10 Glaxo Smith Kline 8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Glaxo Smith Kline 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Glaxo Smith Kline 2016 Non-steroidal Anti-inflammatory Drugs（NSAID） Business Region Distribution Analysis
8.11 Reddy Pharmaceuticals
8.12 Johnson & Johnson

Continued…….

                                                                                                                                                         
CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)